November 2-3, 2011
Washington Duke Inn & Golf Club
Durham, North Carolina

Conference Co-Chairs

Tim Gupton
Hughes Pittman & Gupton

Rosina Maar Pavia
Pappas Ventures

Larry Robbins
Wyrick Robbins

	Sponsor SEBIO 2011
	Register to Attend
	Login to SEBIO/Connect (SEBIO Investor Forum Networking)
	View the Entire 2011 SEBIO Investor Forum Attendee Handout (~13MB)
	View the SEBIO Investor Forum Brochure
	Read about SEBIO 2010
	Contact Us

About the Southeast BIO Investor Forum

The 13th Annual Southeast BIO (SEBIO) Investor Forum will be held November 2-3, 2011 at the Washington Duke Inn in Durham, NC. Recognized as the Southeast region's premier life sciences venture capital conference, this event connects emerging life science companies with potential investors in a forum that provides meaningful networking opportunities. SEBIO’s past presenting companies have raised more than $2.5 billion collectively in private and public funding since the inaugural conference in 1999.

The SEBIO Investor Forum also draws representatives from the region’s top research universities and institutes, features an online partnering system to help conference attendees arrange meetings with one another, and offers investors the opportunity to hear from senior business development executives of major pharma/biotech and medical device companies who are invited to present their strategic partnering goals. Past SEBIO conferences have featured speakers and sessions from key industry leaders including John Martin, CEO of Gilead Sciences; Andrew von Eschenbach, in his role as Commissioner of the FDA; and Matthew Emmens, in his role as CEO of Shire Pharmaceuticals, among many others.

Over 400 people are expected to attend SEBIO 2011 to see the region’s best early and later stage life sciences companies and network with investors representing more than 30 regional and national venture funds. The theme for SEBIO 2011, Data Driven Deals, will highlight the well known fact that data drives grants, corporate partnerships, investments and exits. Home to one of the largest concentrations of CROs in the world and a leader in the biotechnology industry, North Carolina is well positioned to host the Southeast region’s preeminent investment conference.

North Carolina is recognized as a global hub for the biotechnology industry with 538 life sciences companies that employ 58,495 people. The state is home to multiple world class research parks and institutions including, among others, Research Triangle Park, Piedmont Triad Research Park, NC Research Campus in Kannapolis, the David H. Murdock Research Institute, and Research Triangle Institute International. North Carolina’s research universities, including Duke University, the University of North Carolina at Chapel Hill, North Carolina State University, and Wake Forest University, bring in more than $1.3 billion annually in sponsored life science research funding. The state of North Carolina has invested significantly in the biotechnology industry by establishing the North Carolina Biotechnology Center, which supports biotechnology research, business, education and strategic policy statewide. North Carolina’s Centers of Innovation for Medical Devices, Nanobiotechnology and Drug Discovery coordinate research in emerging sectors and speed products to the market. North Carolina companies have raised $1.5 billion in venture capital funding over the last 5 years and the recently established NC Innovation fund, a $232.3 million diversified investment Partnership sponsored by the North Carolina Retirement Systems, will offer emerging companies an additional source of capital.

The SEBIO Investor Forum has rotated around the Southeast over the years: 1999 – Atlanta, GA; 2000 – Chapel Hill, NC; 2001 – Birmingham, AL; 2002 – Atlanta, GA; 2003 – Pinehurst, NC; 2004 – Miami, FL; 2005 – Charleston, SC; 2006 – Atlanta, GA; 2007 – Pinehurst, NC; 2008 – Palm Beach, FL; 2009 – Charleston, SC; and 2010 – Atlanta, GA.